Morning Overview on MSN
Compact CRISPR tool boosts in-body gene editing to 90% in lab tests
For the millions of people living with genetic diseases like muscular dystrophy and inherited liver disorders, one of the ...
A research team has discovered an enhanced CRISPR gene-editing system that could enable targeted delivery inside the human ...
A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.
The CRISPR-Cas gene-editing system has long been the focus of research as a promising tool in genome editing. However, the ...
CRISPR Cas9 gene therapy explained with DNA scissors, hereditary diseases treatment, and designer babies ethical dilemmas ...
NIH-funded UT team and colleagues from Metagenomi Thereapeutics discovered highly efficient enzyme could enable targeted gene editing within the human body.
The global cell therapy technologies market is set to grow from USD 4.41 billion in 2025 to USD 7.91 billion by 2030, ...
Recent commentary has highlighted CRISPR Therapeutics’ expanding gene-editing pipeline, including cardiovascular candidates like CTX310 and CTX320 and programs in type 1 diabetes, alongside fresh Buy ...
Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...
Now, following up on that success, a large Chinese collaboration has followed up with a description of an improved gene ...
There are plenty of reasons, though, to be bullish on the stock, not the least of which is its improved cash position. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results